Autologous bone marrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral ischaemia;Elörehaladott perifériás artériás érbetegségben szenvedok kezelése autológ csontveloi, vagy periférias vérbol származó ossejtekkel

Orvosi Hetilap

Volumn 147, Issue 25, 2006, Pages 1155-1160

  Boda, Zoltán ^a,b   Veréb, Zoltán ^b   Rajnavolgji, Éva ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Immunologiai Intézet ^*  (Hungary)

Author keywords

Angiogenic growth differentiation factor; Autologous stem cell therapy; Endothelial progenitor cell; Peripheral arterial disorder

Indexed keywords

ANGIOGENESIS; ARTERY DISEASE; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL STUDY; EXPERIMENTAL STUDY; GANGRENE; HUMAN; LEG BLOOD FLOW; LIMB AMPUTATION; LIMB BLOOD VESSEL; LIMB ISCHEMIA; LIMB PAIN; NEOVASCULARIZATION (PATHOLOGY); PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERIPHERAL ISCHEMIA; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; ENDOTHELIUM CELL; ISCHEMIA; LIMB; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; TREATMENT OUTCOME; VASCULARIZATION;

ARTERIAL OCCLUSIVE DISEASES; BONE MARROW TRANSPLANTATION; CLINICAL TRIALS; ENDOTHELIAL CELLS; EXTREMITIES; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 33748757546     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Akar, A. R., Durdu, S., Arikbuka, M. és mtsai: Implantation of autologous bone marrow mononuclear cells for Buerger's disease with retractable limb ischaemia. Bone Marrow Transplant., 2005, 36, S47 (abstr.).
2. Asahara, T., Kawamoto, A.: Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell. Physiol., 2004, 287, C572-C579.
3. Bartsch, T., Falke, T., Brehm, M. és mtsai: Intra-arterial and intra-muscular transplantation of adult, autologous bone marrow stem cells. Novel treatment for therapy-refractory peripheral arterial occlusive disease. Dtsch. Med. Wochenschr., 2006. 131, 79-83.
4. Boda Z.: Antithrombotikus terápia perifériás artériás érbetegségekben. In Thrombosis és vérzékenység. Szerk.: Boda, Z., Medicina Kiadó, Budapest. 2006.
5. Boda Z.: Antikoaguláns terápia perifériás artériás érbetegségben. In: Antikoaguláns terápia. Springer Kiadó, Budapest. 2003, 147-151. old.
6. Donnelly, J. M., Yeung, J. M. C.: Therapeutic angiogenesis: a step forward in intermittent claudication. Lancet, 2002, 359, 2048-2050.
7. Farkas K.: Új vizsgálatok és preventív kezelési irányelvek az angiológiában - a boka/kar index jelentosége. Metabolizmus, 2006, 4 (Suppl. A), A59-A61.
8. Higashi, Y., Kimura, M., Hara, K. és mtsai: Autologous bone marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation, 2004, 109, 1215-1218.
9. Huang, P. P., Li, S. Z., Han, M. Z. és mtsai: Autologous transplantation of peripheral blood stem cells as an effective therapeutic approuch for severe arteriosclerosis obliterans of lower extremities. Thromb. Haemost., 2004, 91, 606-609.
10. Hughes, G. C., Annex, B. H.: Angiogenic therapy for coronary artery and peripheral arterial disease. Expert Rev. Cardiovasc. Ther., 2005, 3, 521-535.
11. Irrera, G., Console, G., Martino, M. és mtsai: Therapeutic angiogenesis after infusion of bone marrow mononuclear cells for Buerger's disease: case report. Bone Marrow Transplant., 2005, 36, S92 (abstr.).
12. Kawamura, A., Horie, T., Tsuda, I. és mtsai: Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Therap. Apheresis Dialys., 2005, 9, 59-63.
13. Kim, S. W., Han, H., Chae, G. T., Lee, S. H. és mtsai: Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells, 2006, PMID 16497946.
14. Lazarous, D. F., Unger, E. F., Epstein, S E. és mtsai: Basin fibroblast growth factor in paients with intermittent claudication: results of a phase I trial. J. Am. Coll. Cardiol., 2000, 36, 1239-1244.
15. Lederman, R. J., Mendelsohn, F. O., Anderson, R. D. és mtsai: Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet, 2002, 359, 2053-2058.
16. Lenk, K., Adams, V., Lurz, P. és mtsai: Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur. Heart J., 2005, 26, 1903-1909.
17. Meskó É.: Arteriosclerosis obliterans. In Vascularis Medicina. Szerk.: Meskó É. Therapia Kiadó, Budapest. 2004, 188-192. old.
18. Meskó É.: Thromboangiitis obliterans (Winiwarter-Buerger kór). In Vascularis Medicina. Szerk.: Meskó É. Therapia Kiadó, Budapest. 2004, 193-196. old.
19. Pécsvárady Zs.: Génterápia szerepe az arteriosclerosis obliterans kezelésében. In: Vascularis Medicina. Szerk.: Meskó É. Therapia Kiadó, Budapest. 2004, 224-227. old.
20. Rajagopalan, S., Mohler, E. R., Lederman, R. J. és mtsai: Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease. A Phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor-121 in patients with disabling intermittent claudication. Circulation, 2003, 108, 1933-1938.
21. Rosenzweig, A.: Circulating endothelial progenitors - cells as biomarkers. N. Engl. J. Med., 2005, 353, 1055-1057.
22. van Royen, N., Piek, J. J., Legemate, D. A. és mtsai: Design of the START-trial: stimulation of arteriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial. Vasc. Med., 2003, 8, 191-196.
23. Sánchez-Guijo, F. M., Gonzáles-Porras, J. R., Lopez-Holgado, N.: Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in critical limb ischaemia of the lower extremities. Bone Marrow Transplant., 2006, 37, S226 (abstr.)
24. Shyu, K. G., Chang, H., Wang, B. W. és mtsai: Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Amer. J. Med., 2003, 114, 85-92.
25. Staudacher, D. L., Preis, M., Lewis, B. S. és mtsai: Cellular and molecular therapeutic modalities for arterial obstructive syndrome. Pharmacology, Therapeutics, 2006, 109, 263-273.
26. Tateishi-Yuyama, E., Matsubara, H., Murohara, T. és mtsai: Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone marrow cells: a pilot study and a randomized controlled trial. Lancet, 2002, 360, 427-35.
27. Vértesaljai M., Piróth Zs., Fontos G. és mtsai: Ossejtek alkalmazása a cardiovascularis betegségek kezelésében. Orv. Hetil., 2005, 146, 2383-2388.
28. Vértesaljai M., Piróth Zs., Fontos G. és mtsai: Akut szívizom-infarctusban végzett elso magyar autológ csontveloi ossejt transzplantációk során szerzett tapasztalataink. Orv. Hetil., 2006, 147, 3-6.
29. Yamamoto, K., Kondo, T., Suzuki, S. és mtsai: Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 192-196.
30. Yang, X. F., Wu, Y. X., Wang, H. M. és mtsai: Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder. Zhonghua Nei Ke Za Zhi, 2005, 44, 95-98.